Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Gp100 antigen"'
Autor:
Mahmoud Reza Jaafari, Zahra Gholizadeh, Ali Badiee, Mona Yazdani, Amin Reza Nikpoor, Nema Mohamadian Roshan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
Lack of pre-existing tumor infiltrated T cells resulting in resistance to programmed cell death protein 1 (PD-1) blockade therapies can be solved by combining with anti-cancer vaccines and CpG-ODN in increasing T cell expansion and infiltration. Ther
Autor:
Alexander Seifalian, Ali Badiee, Nema Mohamadian Roshan, Mona Yazdani, Amin Reza Nikpoor, Zahra Gholizadeh, Mahmoud Reza Jaafari
Publikováno v:
International immunopharmacology. 98
Dendritic cell (DC) vaccination can be achieved via straight loading of vaccine into DCs ex vivo or administration to DCs in vivo. However, there is no certain consensus on which approach is preferable, and each strategy has its advantages and disadv
Autor:
Alvin Pratama, Douglas S. Jones, Kate L. Stokes, Thomas Lars Andresen, Hólmfridur Halldórsdóttir, Gulzar Ahmad, Jonathan Nardozzi, Katharine Sackton, Ditte Elisabeth Jæhger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Acquired resistance is a major limiting factor for durable T cell therapies in solid tumors. Antigen escape pathways such as insufficient antigen coverage or loss of target antigen remain major resistance mechanisms that need to be address
Autor:
Dorian A. Stolk, Hakan Kalay, Martino Ambrosini, Jana Vree, van Kooyk Y, Sanne Duinkerken, Joyce Lübbers
Publikováno v:
Biorxiv. Cold Spring Harbor Laboratory Press
Biorxiv
Duinkerken, S, Lübbers, J, Stolk, DA, Vree, J, Ambrosini, M, Kalay, H & van Kooyk, Y 2019, ' Comparison of intradermal injection and epicutaneous laser microporation for antitumor vaccine delivery in a human skin explant model ', Biorxiv . https://doi.org/10.1101/861930
Biorxiv
Duinkerken, S, Lübbers, J, Stolk, DA, Vree, J, Ambrosini, M, Kalay, H & van Kooyk, Y 2019, ' Comparison of intradermal injection and epicutaneous laser microporation for antitumor vaccine delivery in a human skin explant model ', Biorxiv . https://doi.org/10.1101/861930
Human skin is a prime vaccination site containing multiple antigen presenting cells (APC), including Langerhans cells (LC) and dendritic cells (DC). APC deliver antigens to lymph nodes for induction of adaptive immunity through stimulating antigen sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003630b367880007a9ba7bcc9a66c38f
https://doi.org/10.1101/861930
https://doi.org/10.1101/861930
Autor:
Emma Leach, Sarnjeet Kaur, Revashnee Naidoo, Sarah Stanhope, Koustubh Ranade, Marcus O. Butler, Alexander N. Shoushtari, Laura C. Collins, Shaad Essa Abdullah
Publikováno v:
Cancer Research. 81:517-517
Background: Tebentafusp is a unique investigational TCR-anti-CD3 bispecific fusion protein that targets melanoma-expressed gp100 antigen and has shown monotherapy activity in advanced metastatic melanoma [1, 2, 3]. In a phase I/II trial (NCT02570308)
Autor:
Hakim Echchannaoui, Ugur Sahin, Philippe Guillaume, Sebastian Klobuch, Simone Thomas, Matthias Birtel, Ralf-Holger Voss, Hans J. Stauss, Tana Omokoko, Matthias Theobald, Wolfgang Herr, Pedro Romero, Oezlem Yildiz, Diana Knies, Shao-An Xue
Publikováno v:
Oncotarget, vol. 7, no. 16, pp. 21199-21221
Oncotarget
Oncotarget
Immunotherapy of cancer envisions the adoptive transfer of T-cells genetically engineered with tumor-specific heterodimeric α/β T-cell receptors (TCRα/β). However, potential mispairing of introduced TCRα/β-chains with endogenous β/α-ones may
Autor:
Mario Sznol, Avinash Gupta, Omid Hamid, Mark R. Middleton, T.R. Jeffry Evans, Neil Steven, Alan Anthoney, Alexander N. Shoushtari, Cheryl McAlpine, Jeffrey R. Infante, Victoria K Woodcock, Philippa Corrie
Publikováno v:
Journal of Clinical Oncology. 37:9523-9523
9523 Background: ImmTAC molecules are unique TCR–anti-CD3 bispecifics that redirect T cells against intracellular antigens. IMCgp100, an ImmTAC targeting melanocyte-expressed gp100 antigen, has demonstrated monotherapy activity in advanced melanoma
Autor:
Paul Nathan, Leonel Hernandez-Aya, Marlana Orloff, Nicola Little, Jennifer Visich, Ann-Marie Hulstine, Joseph J. Sacco, Christina M. Coughlin, Takami Sato, Richard D. Carvajal
Publikováno v:
Journal of Clinical Oncology. 36:9521-9521
9521Background: IMCgp100 is a bispecific biologic comprised of a soluble T cell receptor recognizing the gp100 antigen fused to a scFV anti-CD3 and redirects T cell lysis of melanoma cells expressi...
Publikováno v:
Journal for Immunotherapy of Cancer
It is well known that CD8+ T cell infiltration of tumors is correlated with positive patient prognosis. Because of this, many viral vaccine vectors have been created to induce expansion and infiltration of tumor-specific CD8+ T cells. Cytomegalovirus
Autor:
Ena Wang, Steven A. Rosenberg, Udai S. Kammula, Patricia Fetsch, Andrea Abati, Janice N. Cormier, Adam I. Riker, Seth M. Steinberg, Kang Hun Lee, Monica C. Panelli, Francesco M. Marincola
Publikováno v:
Surgery. 126:112-120
Background: Melanoma antigen (MA)–specific vaccination strongly enhances antitumor reactivity in vivo and is capable of producing strong cytotoxic T lymphocyte responses in vitro. Furthermore, specific human leukocyte antigen–restricted T cell ac